Maryland Tribune
SEE OTHER BRANDS

The most trusted news from Maryland

Maryland Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tribune.

Press releases published on April 28, 2025

Revealing the Hidden Realities of Mars and Earth: 'Polar Hole Light in Europe's Clouds'

Revealing the Hidden Realities of Mars and Earth: 'Polar Hole Light in Europe's Clouds'

Author Ruth Leedy Carr Explores the Hollow Planet Theory in Her Provocative Book PRESTON, MD, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- Atticus Publishing proudly presents author Ruth Leedy Carr's book, "Polar Hole Light in Europe's Clouds," …

HanaCon 2025 Brings Anime, Art, and Asian Pop Culture to Life in the DMV

HanaCon 2025 Brings Anime, Art, and Asian Pop Culture to Life in the DMV

Experience the Ultimate Fandom Adventure at HanaCon! SILVER SPRING, MD, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- HanaCon is excited to announce the launch of its inaugural Anime, Art, and Asian Pop Culture Convention, set to energize the …

Renowned Physicist Dr. Young Suh Kim Honored By Close Up Radio in the Field of Science

Renowned Physicist Dr. Young Suh Kim Honored By Close Up Radio in the Field of Science

Close Up Radio honors one of our most respected guests, Dr. Young Suh Kim BELTSVILLE, MD, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- How do the orbits of the hydrogen atom appear to you while you are in motion? Einstein asked this question in …

Capital Bancorp, Inc. Announces Strong First Quarter Results and Successful IFH Conversion; Continued Strong Organic Loan and Deposit Growth; NIM and Fee Income Drives Robust Returns

Capital Bancorp, Inc. Announces Strong First Quarter Results and Successful IFH Conversion; Continued Strong Organic Loan and Deposit Growth; NIM and Fee Income Drives Robust Returns

First Quarter 2025 Highlights Net Income of $13.9 million, or $0.82 per share, and return on average assets ("ROA") of 1.75% Core net income(1) of $14.9 million, or $0.88 per share, and core ROA(1) of 1.87% Book value per common share of $22.19 at March 31 …

TeraWulf Schedules Conference Call for First Quarter 2025 Financial Results

TeraWulf Schedules Conference Call for First Quarter 2025 Financial Results

EASTON, Md., April 28, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, next-generation digital infrastructure powered by predominantly zero-carbon energy, today …

Huntress Empowers Businesses to Take Control of Their Identity Security with Enhanced Managed Identity Threat Detection & Response Solution

Huntress Empowers Businesses to Take Control of Their Identity Security with Enhanced Managed Identity Threat Detection & Response Solution

COLUMBIA, Md. and SAN FRANCISCO, CA, April 28, 2025 (GLOBE NEWSWIRE) -- Today, at the RSA Conference, Huntress unveiled its newly enhanced Managed Identity Threat Detection and Response (ITDR) solution, purpose-built to wreck hacker identity tradecraft, …

TeraWulf Announces Participation in Upcoming Investor and Industry Conferences

TeraWulf Announces Participation in Upcoming Investor and Industry Conferences

EASTON, Md., April 28, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), which owns and operates vertically integrated, next-generation digital infrastructure primarily powered by zero-carbon energy, today announced that …

Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax

Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax

ROCKVILLE, Md. and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service